Test Price
1,300 AED✅ Home Collection Available
Anti-NMO (Neuromyelitis Optica) Panel, Serum in UAE | 1300 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Anti-NMO (Neuromyelitis Optica) Panel detects autoantibodies against aquaporin-4 (AQP4) to diagnose NMOSD, a severe autoimmune demyelinating disorder distinct from Multiple Sclerosis. The cell-based indirect immunofluorescence assay (CBA-IFA) provides the highest diagnostic sensitivity for confirming AQP4-IgG seropositivity, enabling early and precise therapeutic intervention.
| Feature | Our Test (Anti-NMO Panel) | Closest Alternative (ELISA) |
|---|---|---|
| Methodology | Cell-Based Indirect Immunofluorescence Assay (CBA-IFA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Diagnostic Sensitivity | 99.9% (ISO-validated) | ~70–80% |
| Turnaround Time | Same Day (if sample received by 9 AM) | 2–3 Days |
Physician Insight & Safety Protocols
“As a General Practitioner, I frequently encounter patients with neurological symptoms that require differentiation between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. The Anti-NMO Panel using the cell-based assay for AQP4 antibodies delivers exceptional diagnostic clarity. A positive result warrants prompt neurology referral for targeted immunotherapy. Accurate diagnosis through this test can fundamentally alter disease progression and prevent permanent neurological damage. Always discuss your results with a specialist before making any treatment decisions.”
— Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132
Advisory Notice
⚠️ Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Biotin Interference: High-dose biotin supplementation (≥5 mg/day) within 72 hours prior to blood draw may produce false-negative results. Discontinue biotin as advised by your physician.
- Active Infection & Pregnancy: Severe systemic infection or pregnancy may alter antibody titers; results in these contexts require cautious interpretation by a neurologist.
- Emergency Red Flags: Sudden severe vision loss, bilateral leg weakness with a sensory level, or intractable vomiting with hiccups — these symptoms require immediate emergency department evaluation.
Patient FAQ & Clinical Guidance
1. What is the Anti-NMO Panel used for?
It identifies aquaporin-4 autoantibodies to provide a definitive diagnosis of neuromyelitis optica spectrum disorder, distinguishing it from multiple sclerosis. This distinction is critical for selecting appropriate immunotherapy and preventing relapse-associated disability.
2. Do I need to fast before this test?
No fasting or special preparation is required. Serum can be drawn at any time of day, ensuring maximum convenience for your schedule. You may eat, drink, and take prescribed medications as usual unless directed otherwise by your physician.
3. How quickly will I receive my results?
Samples collected by 9 AM on testing days are reported the same day, enabling rapid clinical decision-making. Results will be delivered electronically via secure channels and discussed with you during a telephonic clinical guidance session.
UAE Regulatory & Data Privacy Adherence
UAE Healthcare Compliance & Data Protection
- Data Privacy: All personal health information is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring strict confidentiality and lawful processing.
- Health Data Governance: The use of information and communication technology in health fields is governed by Federal Law No. 2 of 2019, ensuring secure digital handling of medical records.
- Medical Liability & Patient Safety: Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, safeguarding your rights throughout the diagnostic pathway.
- Quality Accreditation: Laboratory accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | Anti-NMO (Neuromyelitis Optica) Panel, Serum |
| Price (AED) | 1,300 |
| Turnaround Time | Same Day (if sample received by 9 AM) |
| Sample Type / Matrix | Serum (peripheral blood) |
| Methodology Used | Cell-Based Indirect Immunofluorescence Assay (CBA-IFA) |
| ICD-10-CM Code | G36.0 (Neuromyelitis optica [Devic]) |
| LOINC Code | 94307-6 (Aquaporin 4 IgG Ab [Presence] in Serum by Cell-based assay) |
| DHA Facility License & Address | License #1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians